Zhejiang basic medicine supplement or big surprise, the number of implementation may be as high as 900
-
Last Update: 2014-03-14
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: the Zhejiang basic drug supplement catalogue, which is the heart of the market, has finally entered the final game stage On Thursday, a number of sources told the big wisdom news agency that the number of last basic drug supplements in Zhejiang could reach as many as 380, plus 520 national basic drugs, and a total of about 900 could be implemented According to one source, the supplementary catalogue of Zhejiang is divided into several parts, including recommendation by the letter Committee, recommendation from various prefectural level cities, and recommended clinical varieties (which are recommended by experts) Other catalogues are basically finalized "The final adjustment or alteration is mainly recommended by prefecture level cities" A large local pharmaceutical enterprise official said that in the last adjustment, antibiotics became the focus of the adjustment "There were many varieties of antibiotics applied for supplementation before There were many enterprises producing antibiotics in Zhejiang Province, and the number of these varieties was strictly controlled in this round of supplementation." many varieties have been transferred out As for whether there will be further changes in the 380 varieties, he said, it depends on the game between the two sides, "it is possible that there will be no adjustment in the end." Another local enterprise added that local protection and traditional Chinese medicine injection will also become a major focus of Zhejiang Province's basic medicine supplement catalogue Interestingly, in September last year, Zhejiang Province issued an internal notice to local health departments and medical institutions to recommend 30 varieties The important selection principle is to strictly control the number of exclusive varieties, and antibacterial drugs and traditional Chinese medicine injections shall not be nominated The industry is still waiting for the final results of the supplement.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.